The most recent report for the Commerce, Justice, Science, and Related Agencies (CSJ) produced by the House of Committee on Appropriations includes a novel section concerning psilocybin, where it demands a Government Accountability Office (GAO) analysis concerning state, local and tribal psilocybin programs’ limits.
The increasing psychedelic reform movement in both local and state legislatures has triggered the request for a report to consider the impact of the federal Controlled Substances Act (CSA) enforcement in jurisdictions with programs that incorporate psilocybin products whether for therapeutic use or as part of religious, Indigenous, or spiritual practices.
